![Susan Wyrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Wyrick
Comptroller/Controller/Auditor chez
SANA BIOTECHNOLOGY, INC.
Fortune : 647 447 $ au 31/05/2026
Profil
Susan D.
Wyrick is currently Principal Accounting Officer at Sana Biotechnology, Inc. since 2024.
Formerly, Ms. Wyrick was Vice President & Controller at Juno Therapeutics, Inc. from 2014 to 2018.
Prior to that, Ms. Wyrick was Chief Accounting Officer & Vice President-Finance at OncoGenex Pharmaceuticals, Inc. in 2014.
Ms. Wyrick completed undergraduate education at the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2026 | 196 196 ( 0,08% ) | 647 447 $ | 31/05/2026 |
Postes actifs de Susan Wyrick
| Sociétés | Poste | Début |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 04/10/2024 |
Anciens postes connus de Susan Wyrick
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/10/2018 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Auditor | 11/06/2014 |
Formation de Susan Wyrick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
